LDHA and non-small cell lung carcinoma: LDHA is overexpressed and associated with poor prognosis in non-small cell lung cancer (NSCLC), where LDHA inhibition by oxamate remarkably increased radiosensitivity through ROS accumulation and cellular ATP depletion (Yang et al., 2021).